Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Transferase other than ribonuclease
Reexamination Certificate
2000-03-23
2003-10-07
Weber, Jon P. (Department: 1651)
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Transferase other than ribonuclease
Reexamination Certificate
active
06630333
ABSTRACT:
FIELD OF THE INVENTION
The present invention is in the fields of molecular biology, protein chemistry and protein purification. Specifically, the invention provides compositions comprising reverse transcriptases (RTs) and methods for the production of such reverse transcriptase enzymes. Such methods provide for reverse transcriptases that are substantially free from contamination by nucleic acids and other unwanted materials or proteins. Compositions comprising the reverse transcriptase enzymes of the present invention may be used in a variety of applications, including synthesis, amplification and sequencing of nucleic acids.
BACKGROUND AND SUMMARY OF THE INVENTION
A variety of techniques may be employed to facilitate the preparation of intracellular proteins from microorganisms. Typically, the initial steps in these techniques involve lysis or rupture of the bacterial cells, to disrupt the bacterial cell wall and allow release of the intracellular proteins into the extracellular milieu. Following this release, the desired proteins are purified from the extracts, typically by a series of chromatographic steps.
Several approaches have proven useful in accomplishing the release of intracellular proteins from bacterial cells. Included among these are the use of chemical lysis, physical methods of disruption, or a combination of chemical and physical approaches (reviewed in Felix, H.,
Anal. Biochem
. 120:211-234 (1982)).
Chemical methods of disruption of the bacterial cell wall that have proven useful include treatment of cells with organic solvents such as toluene (Putnam, S. L., and Koch, A. L.,
Anal. Biochem
. 63:350-360 (1975); Laurent, S. J., and Vannier, F. S.,
Biochimie
59:747-750 (1977); Felix, H.,
Anal. Biochem
. 120:211-234 (1982)), with chaeotropes such as guanidine salts (Hettwer, D., and Wang, H.,
Biotechnol. Bioeng
. 33:886-895 (1989)), with antibiotics such as polymyxin B (Schupp, J. M., et al.,
BioTechniques
19:18-20 (1995); Felix, H.,
Anal. Biochem
. 120:211-234 (1982)), or with enzymes such as lysozyme or lysostaphin (McHenty, C. S., and Kornberg, A.,
J. Biol. Chem
. 252(18):6478-6484 (1977); Cull, M., and McHenry, C. S.,
Meth. Enzymol
. 182:147-153 (1990); Hughes, A. J., Jr., et al.,
J. Cell Biochem. Suppl
. 016 (Part B):84 (1992); Sambrook, J., et al., in
Molecular Cloning: A Laboratory Manual
, 2
nd
ed., Cold Spring Harbor, N.Y.; Cold Spring Harbor Laboratory Press, p. 17-38 (1989); Ausubel, F. M., et al.; in
Current Protocols in Molecular Biology
, New York: John Wiley & Sons, p. 4.4.1-4.47 (1993)). The effects of these various chemical agents may be enhanced by concurrently treating the bacterial cells with detergents such as Triton X-100®, sodium dodecylsulfate (SDS) or Brij 35 (Laurent, S. J., and Vannier, F. S.,
Biochimie
59:747-750 (1977); Felix, H.,
Anal. Biochem
. 120:211-234 (1982); Hettwer, D., and Wang, H.,
Biotechnol. Bioeng
, 33:886-895 (1989); Cull, M., and McHenry, C. S.,
Meth. Enzymol
. 182:147-153 (1990); Schupp, J. M., et al.,
BioTechniques
19:18-20 (1995)), or with proteins or protamines such as bovine serum albumin or spermidine (McHenry, C. H. and Kornberg, A.,
J. Biol. Chem
. 252(18): 6478-6484(1977); Felix, H.,
Anal. Biochem
. 120:211-234 (1982); Hughes, A. J., Jr., et al.,
J. Cell Biochem. Suppl
. 0 16 (Part B):84 (1992)).
In addition to these various chemical treatments a number of physical methods of disruption have been used. These physical methods include osmotic shock, e.g., suspension of the cells in a hypotonic solution in the presence or absence of emulsifiers (Roberts, J. D., and Lieberman, M. W.,
Biochemistry
18:4499-4505 (1979); Felix, H.,
Anal. Biochem
. 120:211-234 (1982)), drying (Mowshowitz, D. B.,
Anal. Biochem
. 70:94-99 (1976)), bead agitation such as ball milling (Felix, H.,
Anal. Biochem
. 120:211-234 (1982); Cull, M., and McHenry, C. S.,
Meth. Enzymol
. 182:182:147-153 (1990)), temperature shock, e.g., freeze-thaw cycling (Lazzarini, R. A., and Johnson L. D.,
Nature New Biol
. 243:17-20 (1975); Felix, H.,
Anal, Biochem
. 120:211234 (1982)), sonication (Amos, H., et al.,
J. Bacteriol
. 94:232-240 (1967); Ausubel, F. M., et al., in
Current Protocols in Molecular Biology
, New York:John Wiley & Sons, pp. 4.4.1-4.47 (1993)) and pressure disruption, e.g., use of a french pressure cell (Ausubel, F. M., et al., in
Current Protocols in Molecular Biology
, New York:John Wiley & Sons, pp. 16.8.6-16.8.8 (1993)). Other approaches combine these chemical and physical methods of disruption, such as lysozyme treatment followed by sonication or pressure treatment, to maximize cell disruption and protein release (Ausubel, F. M., et al., in
Current Protocols in Molecular Biology
, New York:John Wiley & Sons, pp. 4.4.1-4.47 (1993)).
These disruption approaches have several advantages, including their ability to rapidly and completely (in the case of physical methods) disrupt the bacterial cell such that the release of intracellular proteins is maximized. In fact, these approaches have been used in the initial steps of processes for the purification of a Variety of bacterial cytosolic enzymes, including natural and recombinant proteins from mesophilic organisms such as
Escherichia coli, Bacillus subtilis
and
Staphylococcus aureus
(Laurent, S. J., and Vannier, F. S.,
Biochimie
59:747-750 (1977); Cull, M., and McHenry, C. S.,
Meth. Enzymol
. 182:147-153 (1990); Hughes, A. J., Jr., et al.,
J. Cell Biochem. Suppl
. 0 16 (Part B): 84 (1992); Ausubel, F. M., et al., in
Current Protocols in Molecular Biology
, New York: John Wiley & Sons, pp. 4.4.1-4.47 (1993)), as well as phosphatases, restriction enzymes, DNA or RNA polymerases and other proteins from thermophilic bacteria and archaea.
However, these methods possess distinct disadvantages as well. For example, the physical methods by definition involve shearing and fracturing of the bacterial cell walls and plasma membranes. These processes thus result in extracts containing large amounts of particulate matter, such as membrane or cell wall fragments, which must be removed from the extracts, typically by centrifugation, prior to purification of the enzymes. This need for centrifugation limits the batch size capable of being processed in a single preparation to that of available centrifuge space; thus, large production-scale preparations are impracticable if not impossible. Furthermore, physical methods, and may chemical techniques, typically result in the release from the cells not only of the desired intracellular proteins, but also of undesired nucleic acids and membrane lipids (the latter particularly resulting when organic solvents are used). These undesirable cellular components also complicate the subsequent processes for purification of the desired proteins, as they increase the viscosity of the extracts (Sambrook, J., et al., in:
Molecular Cloning: A Laboratory Manual
, 2
nd
ed., Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press, p. 17-38 (1989); Cull, M., and McHenry, C. S.,
Meth. Enzynol
. 182:147-153 (1990)), and bind with high avidity and affinity to nucleic acid-binding proteins such as DNA polymerases, RNA polymerases and restriction enzymes.
One problem associated with these approaches is that the enzyme preparations are typically contaminated with nucleic acids (e.g., RNA and DNA). This contaminating nucleic acid may come not only from the organisms which are the source of the enzyme, but also from unknown organisms present in the reagents and materials used to purify the enzyme after its release from the cells. Since reverse transcriptase enzymes are routinely used in techniques of amplification and synthesis of nucleic acid molecules (e.g., the Polymerase Chain Reaction (PCR), particularly RT-PCR) the presence of contaminating DNA or RNA in the enzyme preparations is a significant problem since it can give rise to spurious amplification or synthesis results. Thus, a need exists for preparation of reverse transcriptase enzymes that are substantially free of contamination by nucleic acids.
Instead of attempting to
Invitrogen Corporation
Sterne Kessler Goldstein & Fox P.L.L.C.
Weber Jon P.
LandOfFree
Substantially pure reverse transriptases and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substantially pure reverse transriptases and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substantially pure reverse transriptases and methods of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3112018